Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2008;10(5):112.
doi: 10.1186/bcr2148. Epub 2008 Oct 7.

On the way to specifically targeting minimal residual disease?

Gerhard Gebauer
Editorial

On the way to specifically targeting minimal residual disease?

Gerhard Gebauer. Breast Cancer Res. 2008.

Abstract

The target of all adjuvant systemic therapies after surgery in breast cancer is the eradication of a minimal subclinical residual disease. Although it is well known that tumor cell dissemination takes place already at an early stage of the disease, little is known about the tumorbiological parameters of these residual cells. Selection of patients eligible for adjuvant endocrine therapies is based on the analysis of receptor expression in the primary tumor - although the analysis is directed against disseminated tumor cells, these cells may vary in receptor expression in comparison with the primary tumor.

PubMed Disclaimer

Comment on

References

    1. Fehm TN, Krawczyck N, Solomayer E, Becker-Pergola G, Durr-Storzer S, Neubauer H, Seeger H, Staebler A, Wallwiener D, Becker S. ER alpha-status of disseminated tumor cells in bone marrow of primary breast cancer patients. Breast Cancer Res. 2008;10:R76. doi: 10.1186/bcr2143. - DOI - PMC - PubMed
    1. Fisher B. Laboratory and clinical research in breast cancer – a personal adventure: the David A. Karnofsky memorial lecture. Cancer Res. 1980;40:3863–3874. - PubMed
    1. Punglia RS, Morrow M, Winer EP, Harris JR. Local therapy and survival in breast cancer. N Engl J Med. 2007;356:2399–2405. doi: 10.1056/NEJMra065241. - DOI - PubMed
    1. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;365:1687–1717. doi: 10.1016/S0140-6736(05)66544-0. - DOI - PubMed
    1. Gebauer G, Fehm T, Merkle E, Beck EP, Lang N, Jager W. Epithelial cells in bone marrow of breast cancer patients at time of primary surgery: clinical outcome during long-term follow-up. J Clin Oncol. 2001;19:3669–3674. - PubMed

MeSH terms